David A. Siegel Idera Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.41 - $0.7 $19,002 - $32,442	-46,347 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.53 - $1.03 $397,247 - $772,009	-749,524 Reduced 94.18%	46,347 $26,000
Q3 2021 Nov 15, 2021	BUY	$1.0 - $1.18 $196,400 - $231,752	196,400 Added 32.76%	795,871 $820,000
Q2 2021 Aug 16, 2021	BUY	$1.01 - $1.58 $444,905 - $695,990	440,500 Added 277.09%	599,471 $719,000
Q1 2021 May 17, 2021	BUY	$1.23 - $5.98 $116,819 - $567,950	94,975 Added 148.41%	158,971 $207,000

Q4 2020 Feb 16, 2021	BUY	$2.09 - $5.18 $23,042 - $57,109	11,025 Added 20.81%	63,996 $235,000
Q3 2020 Nov 16, 2020	SELL	$1.71 - $2.68 $1,622 - $2,543	-949 Reduced 1.76%	52,971 $113,000
Q2 2020 Aug 14, 2020	SELL	$1.23 - $2.12 $568 - $979	-462 Reduced 0.85%	53,920 $97,000
Q1 2020 May 15, 2020	SELL	$1.06 - $2.15 $21,836 - $44,290	-20,600 Reduced 27.47%	54,382 $72,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $2.79 $22,185 - $42,687	-15,300 Reduced 16.95%	74,982 $136,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $3.31 $7,844 - $12,247	-3,700 Reduced 3.94%	90,282 $261,000
Q2 2019 Aug 14, 2019	SELL	$2.37 - $3.97 $3,555 - $5,955	-1,500 Reduced 1.57%	93,982 $251,000
Q1 2019 May 15, 2019	BUY	$2.33 - $3.79 $153,488 - $249,666	65,875 Added 222.5%	95,482 $243,000
Q4 2018 Feb 14, 2019	BUY	$2.77 - $9.38 $15,165 - $51,355	5,475 Added 22.69%	29,607 $82,000
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $133,449 - $274,139	24,132 New	24,132 $215,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.